Company profile: Cytovance Biologics
1.1 - Company Overview
Company description
- Provider of cGMP production of therapeutic proteins and antibodies from mammalian cell culture (CHO), microbial fermentation (E. coli), and transgenic processes. Full-service CDMO offering cell line development, process development, purification development, and stability testing; FDA inspected.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cytovance Biologics
ABL
HQ: United States
Website
- Description: Provider of biotechnology contract research, development, and manufacturing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ABL company profile →
Phastar
HQ: United Kingdom
Website
- Description: Provider of specialist biometrics contract research services, offering statistical consulting, clinical trial reporting, data management, and data science for clinical trials. Also provides rescue trial support and functional services partnerships via expert consultants, in-house projects, FSP-style arrangements, and preferred partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phastar company profile →
iCardiac
HQ: United States
Website
- Description: Provider of cardiac safety biomarkers and ECG-based markers for assessing the cardiac safety profile of drugs in development; offers Dynamic QTbtbsm, a suite of ECG-based cardiac safety markers, used in cardiac clinical trials by pharmaceutical, biotechnology, and medical device companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full iCardiac company profile →
Sterling Pharma Solutions
HQ: United Kingdom
Website
- Description: Provider of small molecule API development and manufacturing services for the global pharmaceutical industry, from pre-clinical to commercial. Offers ADC pre-clinical bioconjugation services with potent cytotoxin handling; PDMO® collaborative API development and integrated project management; hazardous chemistry; high potency and controlled substance API manufacturing; and peptide API development with large-scale chromatography.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sterling Pharma Solutions company profile →
UAS Labs
HQ: United States
Website
- Description: Provider of science-backed probiotic solutions, offering documented strains for gut, immune, and women’s health; co-development of customized formulations, including those based on L. acidophilus DDS-1; and the STRAIN TO SOLUTION process ensuring stability and safety from development to final product. Also provides The Probiotics Institute educational platform and SCIENCE by Chr. Hansen strains supported by human clinical data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full UAS Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cytovance Biologics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cytovance Biologics
2.2 - Growth funds investing in similar companies to Cytovance Biologics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cytovance Biologics
4.2 - Public trading comparable groups for Cytovance Biologics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →